Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?

Eur Heart J. 2024 Jan 1;45(1):67-69. doi: 10.1093/eurheartj/ehad751.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Risk Factors
  • Stroke* / etiology
  • Stroke* / prevention & control

Substances

  • Anticoagulants

Grants and funding